VWA7
geneOn this page
Also known as G7cNG37
Summary
VWA7 (von Willebrand factor A domain containing 7, HGNC:13939) is a protein-coding gene on chromosome 6p21.33, encoding von Willebrand factor A domain-containing protein 7 (Q9Y334).
Predicted to be located in extracellular region.
Source: NCBI Gene 80737 — RefSeq curated summary.
At a glance
- GWAS associations: 26
- Clinical variants (ClinVar): 130 total
- MANE Select transcript:
NM_025258
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13939 |
| Approved symbol | VWA7 |
| Name | von Willebrand factor A domain containing 7 |
| Location | 6p21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | G7c, NG37 |
| Ensembl gene | ENSG00000204396 |
| Ensembl biotype | protein_coding |
| OMIM | 609693 |
| Entrez | 80737 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding_CDS_not_defined, 1 protein_coding, 1 retained_intron
ENST00000375688, ENST00000467576, ENST00000486423, ENST00000487013, ENST00000497645
RefSeq mRNA: 1 — MANE Select: NM_025258
NM_025258
CCDS: CCDS4721
Canonical transcript exons
ENST00000375688 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001745874 | 31766245 | 31766384 |
| ENSE00001747740 | 31775964 | 31776242 |
| ENSE00001760165 | 31773242 | 31773437 |
| ENSE00001789165 | 31765883 | 31766057 |
| ENSE00001834033 | 31765590 | 31765770 |
| ENSE00001894642 | 31777109 | 31777328 |
| ENSE00003464020 | 31767158 | 31767250 |
| ENSE00003471031 | 31767362 | 31767514 |
| ENSE00003480689 | 31766463 | 31766764 |
| ENSE00003498889 | 31772954 | 31773123 |
| ENSE00003515719 | 31775333 | 31775429 |
| ENSE00003555889 | 31770001 | 31770113 |
| ENSE00003572094 | 31776546 | 31776794 |
| ENSE00003590256 | 31767622 | 31767754 |
| ENSE00003606066 | 31769675 | 31769791 |
| ENSE00003644668 | 31769018 | 31769203 |
| ENSE00003689876 | 31774516 | 31774626 |
Expression profiles
Bgee: expression breadth ubiquitous, 130 present calls, max score 94.16.
FANTOM5 (CAGE): breadth broad, TPM avg 1.8905 / max 92.7854, expressed in 558 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 72819 | 0.9530 | 400 |
| 72818 | 0.4634 | 143 |
| 72817 | 0.3367 | 177 |
| 72816 | 0.1374 | 55 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 94.16 | gold quality |
| pituitary gland | UBERON:0000007 | 91.45 | gold quality |
| adenohypophysis | UBERON:0002196 | 88.86 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 85.43 | gold quality |
| fallopian tube | UBERON:0003889 | 85.36 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.26 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.54 | gold quality |
| apex of heart | UBERON:0002098 | 83.59 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 82.49 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.98 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.83 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 81.27 | gold quality |
| metanephros cortex | UBERON:0010533 | 81.09 | gold quality |
| gastrocnemius | UBERON:0001388 | 80.38 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.35 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.33 | gold quality |
| cerebellum | UBERON:0002037 | 80.28 | gold quality |
| muscle of leg | UBERON:0001383 | 79.88 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 79.53 | gold quality |
| heart left ventricle | UBERON:0002084 | 79.46 | gold quality |
| primary visual cortex | UBERON:0002436 | 79.37 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.98 | gold quality |
| body of uterus | UBERON:0009853 | 78.90 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 78.53 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 78.21 | gold quality |
| kidney | UBERON:0002113 | 78.02 | gold quality |
| cortex of kidney | UBERON:0001225 | 77.03 | gold quality |
| muscle tissue | UBERON:0002385 | 76.88 | gold quality |
| hypothalamus | UBERON:0001898 | 76.74 | gold quality |
| pancreas | UBERON:0001264 | 76.60 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7303 | no | 14.71 |
| E-ANND-3 | no | 1.84 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | vwa7 | ENSDARG00000061462 |
| mus_musculus | Vwa7 | ENSMUSG00000007030 |
| rattus_norvegicus | Vwa7 | ENSRNOG00000000860 |
Protein
Protein identifiers
von Willebrand factor A domain-containing protein 7 — Q9Y334 (reviewed: Q9Y334)
Alternative names: Protein G7c
All UniProt accessions (2): Q9Y334, A0A1U9X8T7
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Tissue specificity. Expressed at low level in different cell lines.
Miscellaneous. Found in the major hispocompatibility complex class III region. May be implicated in susceptibility to lung tumors.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y334-1 | 1 | yes |
| Q9Y334-2 | 2 |
RefSeq proteins (1): NP_079534* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR036465 | vWFA_dom_sf | Homologous_superfamily |
| IPR052577 | VWA7 | Family |
| IPR056475 | GBD_Hemicentin/VWA7 | Domain |
| IPR056861 | HMCN1-like_VWA | Domain |
| IPR056862 | VWA7_N | Domain |
| IPR057613 | VWA7_4 | Domain |
| IPR057615 | Ig_VWA7 | Domain |
Pfam: PF23560, PF23610, PF23619, PF25106, PF25107
UniProt features (14 total): sequence variant 6, splice variant 2, signal peptide 1, chain 1, sequence conflict 1, domain 1, region of interest 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y334-F1 | 84.03 | 0.60 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 55
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 91 (showing top):
XU_GH1_AUTOCRINE_TARGETS_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, TGANTCA_AP1_C, TGGNNNNNNKCCAR_UNKNOWN, HNF1_01, TAATTA_CHX10_01, ER_Q6_01, AP1_Q6_01, WNT_UP.V1_DN, IL15_UP.V1_DN, IL21_UP.V1_DN, CEBPZ_TARGET_GENES, IGLV5_37_TARGET_GENES, KMT2D_TARGET_GENES, LCORL_TARGET_GENES
GO Biological Process (1): biological_process (GO:0008150)
GO Molecular Function (1): molecular_function (GO:0003674)
GO Cellular Component (2): extracellular region (GO:0005576), cellular_component (GO:0005575)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
712 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| VWA7 | VARS1 | P26640 | 969 |
| VWA7 | VOPP1 | Q96AW1 | 613 |
| VWA7 | LY6G6C | O95867 | 570 |
| VWA7 | SAPCD1 | Q5SSQ6 | 570 |
| VWA7 | DPY19L4 | Q7Z388 | 528 |
| VWA7 | E7ENX8 | E7ENX8 | 515 |
| VWA7 | TMEM9B | Q9NQ34 | 497 |
| VWA7 | CCNQ | Q8N1B3 | 492 |
| VWA7 | NOC4L | Q9BVI4 | 483 |
| VWA7 | LY6G5C | Q5SRR4 | 480 |
| VWA7 | GK5 | Q6ZS86 | 474 |
| VWA7 | LMLN | Q96KR4 | 473 |
| VWA7 | MSH5 | O43196 | 472 |
| VWA7 | LY6G6F | Q5SQ64 | 465 |
| VWA7 | SLC45A1 | Q9Y2W3 | 464 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CUL2 | ANXA2P2 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): VWA7 (Biochemical Activity), VWA7 (Affinity Capture-MS), VWA7 (Affinity Capture-MS), VWA7 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GTW7, A0A1D5NSK0, A0A1L8HYT7, A0A286YEC0, G7PWZ3, O77755, O88959, P0C0K7, P17490, P23276, P43021, P51882, P59509, P59996, P70505, Q02853, Q04912, Q04962, Q04997, Q0V8J4, Q0VAY3, Q17R55, Q3U435, Q499S5, Q4R7Z5, Q58Y75, Q62190, Q6MG64, Q76MJ5, Q7TN88, Q7Z442, Q80W65, Q8BMN4, Q8CJH3, Q8IVN8, Q8VCS0, Q91X21, Q96KR4, Q96PQ0, Q96S42
Diamond homologs: D3YXG0, Q0V8J4, Q6MG64, Q8NDA2, Q96RW7, Q9JHA8, Q9Y334, A1KZ92, A2AJ76, A2VEC9, A4IGL7, A8WQH2, B0V2N1, B3EWY9, B3EWZ3, B3EWZ8, C0HL12, C5IAW9, D3ZTD8, F1LW30, F1NWE3, G5EBF1, G5ECS8, O08721, O08722, O08747, O14514, O15146, O55005, O60241, O60242, O89026, O95185, O95428, P07996, P11680, P16621, P27918, P35440, P35441
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
130 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 111 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2851 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:31765878:CTCAC:C | donor_loss | 1.0000 |
| 6:31765881:A:AC | donor_gain | 1.0000 |
| 6:31765881:A:AG | donor_loss | 1.0000 |
| 6:31765882:C:CC | donor_gain | 1.0000 |
| 6:31765882:CCTG:C | donor_gain | 1.0000 |
| 6:31766053:GAGCC:G | acceptor_gain | 1.0000 |
| 6:31766054:AGCC:A | acceptor_gain | 1.0000 |
| 6:31766054:AGCCC:A | acceptor_loss | 1.0000 |
| 6:31766055:GCC:G | acceptor_gain | 1.0000 |
| 6:31766055:GCCC:G | acceptor_loss | 1.0000 |
| 6:31766056:CC:C | acceptor_gain | 1.0000 |
| 6:31766056:CCC:C | acceptor_gain | 1.0000 |
| 6:31766056:CCCTG:C | acceptor_loss | 1.0000 |
| 6:31766057:CC:C | acceptor_gain | 1.0000 |
| 6:31766057:CCT:C | acceptor_loss | 1.0000 |
| 6:31766058:C:CC | acceptor_gain | 1.0000 |
| 6:31766058:C:T | acceptor_gain | 1.0000 |
| 6:31766058:CTGGA:C | acceptor_loss | 1.0000 |
| 6:31766059:T:A | acceptor_loss | 1.0000 |
| 6:31766380:CTAAG:C | acceptor_gain | 1.0000 |
| 6:31767246:CTGGG:C | acceptor_gain | 1.0000 |
| 6:31767247:TGGG:T | acceptor_gain | 1.0000 |
| 6:31767249:GGC:G | acceptor_loss | 1.0000 |
| 6:31767250:GC:G | acceptor_loss | 1.0000 |
| 6:31767251:C:CA | acceptor_loss | 1.0000 |
| 6:31767251:C:CC | acceptor_gain | 1.0000 |
| 6:31767252:T:A | acceptor_loss | 1.0000 |
| 6:31767357:CTTA:C | donor_loss | 1.0000 |
| 6:31767358:TTAC:T | donor_loss | 1.0000 |
| 6:31767360:A:AT | donor_loss | 1.0000 |
AlphaMissense
5712 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:31773370:C:A | K263N | 0.993 |
| 6:31773370:C:G | K263N | 0.993 |
| 6:31775412:G:C | S177R | 0.992 |
| 6:31775412:G:T | S177R | 0.992 |
| 6:31775414:T:G | S177R | 0.992 |
| 6:31772964:A:C | F359L | 0.989 |
| 6:31772964:A:T | F359L | 0.989 |
| 6:31772966:A:G | F359L | 0.989 |
| 6:31773090:G:C | S317R | 0.989 |
| 6:31773090:G:T | S317R | 0.989 |
| 6:31773092:T:G | S317R | 0.989 |
| 6:31769751:A:T | V414D | 0.986 |
| 6:31773431:C:G | C243S | 0.985 |
| 6:31773432:A:T | C243S | 0.985 |
| 6:31769195:G:C | F442L | 0.984 |
| 6:31769195:G:T | F442L | 0.984 |
| 6:31769197:A:G | F442L | 0.984 |
| 6:31775424:G:C | F173L | 0.983 |
| 6:31775424:G:T | F173L | 0.983 |
| 6:31775426:A:G | F173L | 0.983 |
| 6:31769728:C:G | D422H | 0.982 |
| 6:31769747:G:C | F415L | 0.980 |
| 6:31769747:G:T | F415L | 0.980 |
| 6:31769749:A:G | F415L | 0.980 |
| 6:31775418:A:C | S175R | 0.980 |
| 6:31775418:A:T | S175R | 0.980 |
| 6:31775420:T:G | S175R | 0.980 |
| 6:31775406:C:A | W179C | 0.979 |
| 6:31775406:C:G | W179C | 0.979 |
| 6:31776132:G:C | D115E | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000014439 (6:31776089 C>T), RS1000115349 (6:31774472 A>C,G), RS1000703950 (6:31772891 G>A,C), RS1001172379 (6:31773188 C>G,T), RS1001199977 (6:31768952 T>C), RS1001452570 (6:31775863 G>A,C,T), RS1001623429 (6:31773505 C>T), RS1002390962 (6:31766182 G>C), RS1002603558 (6:31767304 G>A,C), RS1002853539 (6:31770246 T>C,G), RS1002889255 (6:31771650 C>T), RS1003125693 (6:31776995 G>C), RS1003154138 (6:31777278 C>A), RS1003278650 (6:31770807 C>G,T), RS1004499086 (6:31768299 C>A)
Disease associations
OMIM: gene MIM:609693 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
26 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004131_25 | Inflammatory bowel disease | 2.000000e-31 |
| GCST004133_79 | Ulcerative colitis | 5.000000e-65 |
| GCST004521_114 | Autism spectrum disorder or schizophrenia | 3.000000e-17 |
| GCST004521_117 | Autism spectrum disorder or schizophrenia | 3.000000e-15 |
| GCST004521_126 | Autism spectrum disorder or schizophrenia | 2.000000e-10 |
| GCST004521_154 | Autism spectrum disorder or schizophrenia | 3.000000e-08 |
| GCST004521_17 | Autism spectrum disorder or schizophrenia | 2.000000e-12 |
| GCST004521_209 | Autism spectrum disorder or schizophrenia | 5.000000e-16 |
| GCST004521_211 | Autism spectrum disorder or schizophrenia | 5.000000e-15 |
| GCST004521_213 | Autism spectrum disorder or schizophrenia | 5.000000e-13 |
| GCST004521_224 | Autism spectrum disorder or schizophrenia | 5.000000e-10 |
| GCST004521_227 | Autism spectrum disorder or schizophrenia | 4.000000e-12 |
| GCST004521_265 | Autism spectrum disorder or schizophrenia | 7.000000e-14 |
| GCST004521_281 | Autism spectrum disorder or schizophrenia | 5.000000e-09 |
| GCST004521_296 | Autism spectrum disorder or schizophrenia | 6.000000e-18 |
| GCST004521_45 | Autism spectrum disorder or schizophrenia | 2.000000e-16 |
| GCST004521_70 | Autism spectrum disorder or schizophrenia | 8.000000e-20 |
| GCST004521_81 | Autism spectrum disorder or schizophrenia | 1.000000e-14 |
| GCST004616_18 | Platelet distribution width | 9.000000e-11 |
| GCST008916_111 | Asthma | 2.000000e-14 |
| GCST008916_30 | Asthma | 1.000000e-09 |
| GCST008917_2 | Asthma (childhood onset) | 4.000000e-07 |
| GCST008921_1 | Asthma and major depressive disorder | 2.000000e-16 |
| GCST009864_3 | Fasting plasma glucose | 3.000000e-09 |
| GCST010083_214 | Hemoglobin levels | 2.000000e-35 |
| GCST011766_20 | Chronic obstructive pulmonary disease | 2.000000e-14 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007984 | platelet component distribution width |
| EFO:0004509 | hemoglobin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sulforaphane | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| ferrous chloride | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, increases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Lipopolysaccharides | increases expression, affects cotreatment | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_F1PN | HyCyte HEK293T KO-hVWA7 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): childhood onset asthma, chronic obstructive pulmonary disease